Physician profile
Gilad M Jaffe
NPI 1891157392
$1,273.16
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $113 · 2021: $371 · 2022: $489 · 2023: $300.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $300.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $299.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $414.98 | 2021-2022 | |
| La Jolla Pharmaceutical Company | $235.00 | 2020-2021 | |
| Pulmonx Corporation | $163.97 | 2023 | Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console, Zephyr Endobronchial Valve |
| Astrazeneca Pharmaceuticals Lp | $159.09 | 2022-2023 | Breztri |
| Actelion Pharmaceuticals US, INC. | $144.37 | 2022-2023 | Opsumit, Uptravi |
| Glaxosmithkline, LLC. | $68.05 | 2022-2023 | Trelegy Ellipta |
| Grifols USA, LLC | $24.24 | 2023 | Prolastin-C Liquid |
| Electromed, INC. | $21.25 | 2023 | Smartvest |
| Genzyme Corporation | $15.10 | 2022 | |
| Amgen INC. | $13.60 | 2022 | |
| United Therapeutics Corporation | $13.51 | 2023 | Tyvaso |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gilad Jaffe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.